[Diseases and dermatoglyphics].
D000014:Abnormalities, Drug-Induced / Q000175:diagnosis; D000015:Abnormalities, Multiple; D001842:Bone and Bones / Q000002:abnormalities; D002869:Chromosome Aberrations / Q000175:diagnosis*; D025063:Chromosome Disorders; D000013:Congenital Abnormalities / Q000175:diagnosis*; D003878:Dermatoglyphics; D004314:Down Syndrome / Q000175:diagnosis; D004827:Epilepsy / Q000175:diagnosis; D005145:Face / Q000002:abnormalities; D005260:Female; D006130:Growth Disorders / Q000175:diagnosis; D006330:Heart Defects, Congenital / Q000175:diagnosis; D006527:Hepatolenticular Degeneration / Q000175:diagnosis; D006801:Humans; D008607:Intellectual Disability / Q000175:diagnosis; D007713:Klinefelter Syndrome / Q000175:diagnosis; D007938:Leukemia / Q000175:diagnosis; D008297:Male; D008831:Microcephaly / Q000175:diagnosis; D009133:Muscular Atrophy / Q000175:diagnosis; D012409:Rubella / Q000175:diagnosis; D012559:Schizophrenia / Q000175:diagnosis; D012729:Sex Chromosome Aberrations / Q000175:diagnosis; D013792:Thalidomide / Q000009:adverse effects; D014314:Trisomy; D014424:Turner Syndrome / Q000175:diagnosis; D014849:Waardenburg Syndrome / Q000175:diagnosis
D013792:Thalidomide